Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04140669 · ClinicalTrials.gov registry record
Automated Myocardial Performance Index Using Samsung HERA W10
A clinical trial, sponsored by Mayo Clinic.
- Terminated
- Registry status
- 7
- Enrollment target
NCT04140669: Clinical Trial study, sponsored by Mayo Clinic.
NCT04140669 is a clinical trial that was terminated before completion, run by Mayo Clinic. The registered enrollment target is 7 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04140669 was terminated before completion, sponsored by Mayo Clinic.
- TERMINATED
- Registry status
- 7 participants
- Enrollment target
Study Summary
Researchers are using Myocardial performance index (MPI) to assess fetal cardiac function before, during, and after fetal surgery in order to gain more knowledge about fetal cardiac function in high risk pregnancies and the relationship to outcomes of fetal surgical interventions.
Interventions
- DEVICE Automated Myocardial Performance Index (MPI)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2019-09-16 |
| Est. Completion | 2020-07-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04140669
The ClinicalTrials.gov registry entry for NCT04140669 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 7 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Automated Myocardial Performance Index (MPI) is the first listed.
NCT04140669 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04140669 about?
NCT04140669 is a clinical study titled "Automated Myocardial Performance Index Using Samsung HERA W10". Researchers are using Myocardial performance index (MPI) to assess fetal cardiac function before, during, and after fetal surgery in order to gain more knowledge about fetal cardiac function in high risk pregnancies and the relationship to outcomes of fetal surgical interventions.
What is the current status of trial NCT04140669?
This trial is currently terminated. The enrollment target is 7 participants. The study started on 2019-09-16. Estimated completion is 2020-07-07.
What interventions are being tested in trial NCT04140669?
The interventions under investigation include: Automated Myocardial Performance Index (MPI) (DEVICE).
Who is sponsoring clinical trial NCT04140669?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.